Erythrocyte-incorporated 6-mercaptopurine metabolite levels are not affected by recent drug administration during maintenance therapy for childhood acute lymphoblastic leukemia

Background: Childhood acute lymphoblastic leukemia (ALL) maintenance therapy with oral 6-mercaptopurine (6-MP) and methotrexate prevents leukemic relapse by acting against residual lymphoblasts. Non-adherence to oral maintenance therapy significantly increases ALL relapse risk. The levels of intrace...

Descripción completa

Detalles Bibliográficos

Autores principales:	Lauryna Aukstikalne, Ignas Klejus, Maria Thastrup, Tadas Zvirblis, Kjeld Schmiegelow, Goda Elizabeta Vaitkeviciene, Linea Natalie Toksvang
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2023-12-01
Colección:	EJC Paediatric Oncology
Materias:	Leukemia Acute Lymphoblastic Maintenance therapy 6-mercaptopurine Relapse
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S2772610X23000260
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!